Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 336

1.

Primary Care Interventions to Prevent Child Maltreatment: An Evidence Review for the U.S. Preventive Services Task Force [Internet].

Viswanathan M, Fraser JG, Pan H, Morgenlander M, McKeeman JL, Forman-Hoffman VL, Hart LC, Zolotor AJ, Lohr KN, Patel SV, Jonas DE.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Nov.

2.

Primary Care Interventions to Prevent Child Maltreatment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

Viswanathan M, Fraser JG, Pan H, Morgenlander M, McKeeman JL, Forman-Hoffman VL, Hart LC, Zolotor AJ, Lohr KN, Patel S, Jonas DE.

JAMA. 2018 Nov 27;320(20):2129-2140. doi: 10.1001/jama.2018.17647.

PMID:
30480734
3.

Severe calcium pyrophosphate dihydrate deposition disease of the metacarpophalangeal joints.

Rigsbee CA, Sizemore TC, Lohr KM.

BMJ Case Rep. 2018 Sep 28;2018. pii: bcr-2018-226132. doi: 10.1136/bcr-2018-226132.

4.

Definition of Treatment-Resistant Depression in the Medicare Population [Internet].

Gaynes BN, Asher G, Gartlehner G, Hoffman V, Green J, Boland E, Lux L, Weber RP, Randolph C, Bann C, Coker-Schwimmer E, Viswanathan M, Lohr KN.

Rockville, MD: Agency for Healthcare Research and Quality (US); 2018 Feb 9.

5.

Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update [Internet].

Forman-Hoffman V, Middleton JC, Feltner C, Gaynes BN, Weber RP, Bann C, Viswanathan M, Lohr KN, Baker C, Green J.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 May.

6.

Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update [Internet].

Donahue KE, Gartlehner G, Schulman ER, Jonas B, Coker-Schwimmer E, Patel SV, Weber RP, Lohr KN, Bann C, Viswanathan M.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Jul.

7.

Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: An Evidence Review for the U.S. Preventive Services Task Force [Internet].

Gartlehner G, Patel SV, Viswanathan M, Feltner C, Weber RP, Lee R, Mullican K, Boland E, Lux L, Lohr K.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Dec.

8.

Quality improvement, implementation, and dissemination strategies to improve mental health care for children and adolescents: a systematic review.

Forman-Hoffman VL, Middleton JC, McKeeman JL, Stambaugh LF, Christian RB, Gaynes BN, Kane HL, Kahwati LC, Lohr KN, Viswanathan M.

Implement Sci. 2017 Jul 24;12(1):93. doi: 10.1186/s13012-017-0626-4. Review.

9.

Comparative Benefits and Harms of Complementary and Alternative Medicine Therapies for Initial Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.

Asher GN, Gartlehner G, Gaynes BN, Amick HR, Forneris C, Morgan LC, Coker-Schwimmer E, Boland E, Lux LJ, Gaylord S, Bann C, Pierl CB, Lohr KN.

J Altern Complement Med. 2017 Dec;23(12):907-919. doi: 10.1089/acm.2016.0261. Epub 2017 Jul 12. Review.

PMID:
28700248
10.

Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews.

Gartlehner G, Wagner G, Matyas N, Titscher V, Greimel J, Lux L, Gaynes BN, Viswanathan M, Patel S, Lohr KN.

BMJ Open. 2017 Jun 14;7(6):e014912. doi: 10.1136/bmjopen-2016-014912. Review.

11.

Comparative Effectiveness of Treatments for Binge-Eating Disorder: Systematic Review and Network Meta-Analysis.

Peat CM, Berkman ND, Lohr KN, Brownley KA, Bann CM, Cullen K, Quattlebaum MJ, Bulik CM.

Eur Eat Disord Rev. 2017 Sep;25(5):317-328. doi: 10.1002/erv.2517. Epub 2017 May 3. Review.

PMID:
28467032
12.

Preventing and De-escalating Aggressive Behavior Among Adult Psychiatric Patients: A Systematic Review of the Evidence.

Gaynes BN, Brown CL, Lux LJ, Brownley KA, Van Dorn RA, Edlund MJ, Coker-Schwimmer E, Weber RP, Sheitman B, Zarzar T, Viswanathan M, Lohr KN.

Psychiatr Serv. 2017 Aug 1;68(8):819-831. doi: 10.1176/appi.ps.201600314. Epub 2017 Apr 17. Review.

PMID:
28412887
13.

Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease.

Dunn AR, Stout KA, Ozawa M, Lohr KM, Hoffman CA, Bernstein AI, Li Y, Wang M, Sgobio C, Sastry N, Cai H, Caudle WM, Miller GW.

Proc Natl Acad Sci U S A. 2017 Mar 14;114(11):E2253-E2262. doi: 10.1073/pnas.1616892114. Epub 2017 Feb 28.

14.

Patient-Reported Outcomes in Performance Measurement.

Cella D, Hahn EA, Jensen SE, Butt Z, Nowinski CJ, Rothrock N, Lohr KN.

Research Triangle Park (NC): RTI Press; 2015 Sep.

15.

Binge-Eating Disorder in Adults.

Brownley KA, Berkman ND, Peat CM, Lohr KN, Bulik CM.

Ann Intern Med. 2017 Feb 7;166(3):231-232. doi: 10.7326/L16-0621. No abstract available.

PMID:
28166552
16.

Strategies To Improve Mental Health Care for Children and Adolescents [Internet].

Forman-Hoffman VL, Middleton JC, McKeeman JL, Stambaugh LF, Christian RB, Gaynes BN, Kane HL, Kahwati LC, Lohr KN, Viswanathan M.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Dec.

17.

Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain.

Cliburn RA, Dunn AR, Stout KA, Hoffman CA, Lohr KM, Bernstein AI, Winokur EJ, Burkett J, Schmitz Y, Caudle WM, Miller GW.

J Chem Neuroanat. 2017 Oct;83-84:82-90. doi: 10.1016/j.jchemneu.2016.11.003. Epub 2016 Nov 9.

18.

Selective Enhancement of Dopamine Release in the Ventral Pallidum of Methamphetamine-Sensitized Mice.

Stout KA, Dunn AR, Lohr KM, Alter SP, Cliburn RA, Guillot TS, Miller GW.

ACS Chem Neurosci. 2016 Oct 19;7(10):1364-1373. Epub 2016 Aug 18.

19.

Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits.

Trossbach SV, Bader V, Hecher L, Pum ME, Masoud ST, Prikulis I, Schäble S, de Souza Silva MA, Su P, Boulat B, Chwiesko C, Poschmann G, Stühler K, Lohr KM, Stout KA, Oskamp A, Godsave SF, Müller-Schiffmann A, Bilzer T, Steiner H, Peters PJ, Bauer A, Sauvage M, Ramsey AJ, Miller GW, Liu F, Seeman P, Brandon NJ, Huston JP, Korth C.

Mol Psychiatry. 2016 Nov;21(11):1561-1572. doi: 10.1038/mp.2015.194. Epub 2016 Jan 12.

20.

Reduced mitochondrial mass and function add to age-related susceptibility toward diet-induced fatty liver in C57BL/6J mice.

Lohr K, Pachl F, Moghaddas Gholami A, Geillinger KE, Daniel H, Kuster B, Klingenspor M.

Physiol Rep. 2016 Oct;4(19). pii: e12988.

21.

Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression.

Gartlehner G, Gaynes BN, Forneris C, Lohr KN.

Ann Intern Med. 2016 Sep 20;165(6):454. doi: 10.7326/L16-0209. No abstract available.

PMID:
27653717
22.

Strategies To De-escalate Aggressive Behavior in Psychiatric Patients [Internet].

Gaynes BN, Brown C, Lux LJ, Brownley K, Van Dorn R, Edlund M, Coker-Schwimmer E, Zarzar T, Sheitman B, Weber RP, Viswanathan M, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jul.

23.

Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Lohr KM, Masoud ST, Salahpour A, Miller GW.

Eur J Neurosci. 2017 Jan;45(1):20-33. doi: 10.1111/ejn.13357. Epub 2016 Sep 2. Review.

24.

Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis.

Brownley KA, Berkman ND, Peat CM, Lohr KN, Cullen KE, Bann CM, Bulik CM.

Ann Intern Med. 2016 Sep 20;165(6):409-20. doi: 10.7326/M15-2455. Epub 2016 Jun 28. Review.

25.

Total Worker Health® [Internet].

Feltner C, Peterson K, Weber RP, Cluff L, Coker-Schwimmer E, Viswanathan M, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 May.

26.

Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals.

Lohr KM, Chen M, Hoffman CA, McDaniel MJ, Stout KA, Dunn AR, Wang M, Bernstein AI, Miller GW.

Toxicol Sci. 2016 Sep;153(1):79-88. doi: 10.1093/toxsci/kfw106. Epub 2016 Jun 10.

27.

The Effectiveness of Total Worker Health Interventions: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop.

Feltner C, Peterson K, Palmieri Weber R, Cluff L, Coker-Schwimmer E, Viswanathan M, Lohr KN.

Ann Intern Med. 2016 Aug 16;165(4):262-9. doi: 10.7326/M16-0626. Epub 2016 May 31. Review.

PMID:
27240022
28.

Respiratory Syncytial Virus Hospitalizations in Healthy Preterm Infants: Systematic Review.

Mauskopf J, Margulis AV, Samuel M, Lohr KN.

Pediatr Infect Dis J. 2016 Jul;35(7):e229-38. doi: 10.1097/INF.0000000000001163. Review.

29.

Authors' reply to Gøtzsche and Hamilton.

Amick HR, Gartlehner G, Gaynes BN, Lohr KN.

BMJ. 2016 Feb 10;352:i617. doi: 10.1136/bmj.i617. No abstract available.

PMID:
26864955
30.

Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians.

Gartlehner G, Gaynes BN, Amick HR, Asher GN, Morgan LC, Coker-Schwimmer E, Forneris C, Boland E, Lux LJ, Gaylord S, Bann C, Pierl CB, Lohr KN.

Ann Intern Med. 2016 Mar 1;164(5):331-41. doi: 10.7326/M15-1813. Epub 2015 Dec 8. Review.

PMID:
26857743
31.

Mycobacterium marinum Infection After Exposure to Coal Mine Water.

Huaman MA, Ribes JA, Lohr KM, Evans ME.

Open Forum Infect Dis. 2015 Dec 17;3(1):ofv205. doi: 10.1093/ofid/ofv205. eCollection 2016 Jan.

32.

Management and Outcomes of Binge-Eating Disorder [Internet].

Berkman ND, Brownley KA, Peat CM, Lohr KN, Cullen KE, Morgan LC, Bann CM, Wallace IF, Bulik CM.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Dec.

33.

Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder [Internet].

Gartlehner G, Gaynes BN, Amick HR, Asher G, Morgan LC, Coker-Schwimmer E, Forneris C, Boland E, Lux LJ, Gaylord S, Bann C, Pierl CB, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Dec.

34.

Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis.

Amick HR, Gartlehner G, Gaynes BN, Forneris C, Asher GN, Morgan LC, Coker-Schwimmer E, Boland E, Lux LJ, Gaylord S, Bann C, Pierl CB, Lohr KN.

BMJ. 2015 Dec 8;351:h6019. doi: 10.1136/bmj.h6019. Review.

35.

Assessing the Predictive Validity of Strength of Evidence Grades: A Meta-Epidemiological Study [Internet].

Gartlehner G, Dobrescu A, Evans TS, Bann C, Robinson KA, Reston J, Thaler K, Skelly A, Glechner A, Peterson K, Kien C, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Sep.

36.

Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration.

Alter SP, Stout KA, Lohr KM, Taylor TN, Shepherd KR, Wang M, Guillot TS, Miller GW.

Exp Neurol. 2016 Jan;275 Pt 1:17-24. doi: 10.1016/j.expneurol.2015.09.016. Epub 2015 Sep 30.

37.

Comparative Proteomic Analysis of Carbonylated Proteins from the Striatum and Cortex of Pesticide-Treated Mice.

Coughlan C, Walker DI, Lohr KM, Richardson JR, Saba LM, Caudle WM, Fritz KS, Roede JR.

Parkinsons Dis. 2015;2015:812532. doi: 10.1155/2015/812532. Epub 2015 Aug 9.

38.

The predictive validity of quality of evidence grades for the stability of effect estimates was low: a meta-epidemiological study.

Gartlehner G, Dobrescu A, Evans TS, Bann C, Robinson KA, Reston J, Thaler K, Skelly A, Glechner A, Peterson K, Kien C, Lohr KN.

J Clin Epidemiol. 2016 Feb;70:52-60. doi: 10.1016/j.jclinepi.2015.08.018. Epub 2015 Sep 3.

PMID:
26342443
39.

Screening for Speech and Language Delays and Disorders in Children Age 5 Years or Younger: A Systematic Review for the U.S. Preventive Services Task Force [Internet].

Berkman ND, Wallace I, Watson L, Coyne-Beasley T, Cullen K, Wood C, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Jul.

40.

Performance on the adult rheumatology in-training examination and relationship to outcomes on the rheumatology certification examination.

Lohr KM, Clauser A, Hess BJ, Gelber AC, Valeriano-Marcet J, Lipner RS, Haist SA, Hawley JL, Zirkle S, Bolster MB; American College of Rheumatology Committee on Rheumatology Training and Workforce Issues.

Arthritis Rheumatol. 2015 Nov;67(11):3082-90. doi: 10.1002/art.39281.

41.

Screening for Speech and Language Delay in Children 5 Years Old and Younger: A Systematic Review.

Wallace IF, Berkman ND, Watson LR, Coyne-Beasley T, Wood CT, Cullen K, Lohr KN.

Pediatrics. 2015 Aug;136(2):e448-62. doi: 10.1542/peds.2014-3889. Epub 2015 Jul 7. Review.

42.

Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.

Liu G, Sgobio C, Gu X, Sun L, Lin X, Yu J, Parisiadou L, Xie C, Sastry N, Ding J, Lohr KM, Miller GW, Mateo Y, Lovinger DM, Cai H.

Hum Mol Genet. 2015 Sep 15;24(18):5299-312. doi: 10.1093/hmg/ddv249. Epub 2015 Jun 29.

43.

Effectiveness of Portable Monitoring Devices for Diagnosing Obstructive Sleep Apnea: Update of a Systematic Review [Internet].

Lux L, Boehlecke B, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2004 Sep 1.

44.

Medication Therapy Management Interventions in Outpatient Settings [Internet].

Viswanathan M, Kahwati LC, Golin CE, Blalock S, Coker-Schwimmer E, Posey R, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Nov.

45.

An interview with Mark Graber.

Lohr K.

Jt Comm J Qual Patient Saf. 2015 May;41(5):195-8. No abstract available.

PMID:
25977245
46.

Comparison of Effects as Evidence Evolves From Single Trials to High-Quality Bodies of Evidence [Internet].

Gartlehner G, Dobrescu A, Evans TS, Thaler K, Nussbaumer B, Sommer I, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Mar.

47.

Average effect estimates remain similar as evidence evolves from single trials to high-quality bodies of evidence: a meta-epidemiologic study.

Gartlehner G, Dobrescu A, Evans TS, Thaler K, Nussbaumer B, Sommer I, Lohr KN.

J Clin Epidemiol. 2016 Jan;69:16-22. doi: 10.1016/j.jclinepi.2015.02.013. Epub 2015 Feb 28.

PMID:
25840752
48.

Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity.

Lohr KM, Stout KA, Dunn AR, Wang M, Salahpour A, Guillot TS, Miller GW.

ACS Chem Neurosci. 2015 May 20;6(5):790-9. doi: 10.1021/acschemneuro.5b00010. Epub 2015 Mar 9.

49.

Grading the strength of a body of evidence when assessing health care interventions: an EPC update.

Berkman ND, Lohr KN, Ansari MT, Balk EM, Kane R, McDonagh M, Morton SC, Viswanathan M, Bass EB, Butler M, Gartlehner G, Hartling L, McPheeters M, Morgan LC, Reston J, Sista P, Whitlock E, Chang S.

J Clin Epidemiol. 2015 Nov;68(11):1312-24. doi: 10.1016/j.jclinepi.2014.11.023. Epub 2014 Dec 20.

PMID:
25721570
50.

Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic Treatment for Hospital-Acquired Pneumonia [Internet].

Lux LJ, Posey RE, Daniels LS, Henke DC, Durham C, Jonas DE, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Nov.

Supplemental Content

Support Center